MedTrace Logo

The Preeclampsia Registry

NCT06377878 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2024-04-22

No results posted yet for this study

Summary

The purpose of The Preeclampsia Registry is to collect and store medical and other information from women who have been medically diagnosed with preeclampsia or a related hypertensive (high blood pressure) disorder of pregnancy such as eclampsia or HELLP syndrome, their family members, and women who have not had preeclampsia to serve as controls. Information from participants will be used for medical research to try to understand why preeclampsia occurs, how to predict it better, and to develop experimental clinical trials of new treatments. The Registry will consist of a web-based survey and mechanism for collecting and reviewing medical records. This data will be utilized for immediate investigator-driven cross-sectional research projects (after proposal review by the Registry's scientific advisory board and as directed by the PI). Participants may also choose to be contacted regarding possible participation in future studies, about providing a biospecimen, as well as investigator-driven clinical trials. The Registry is anticipated to exist long-term and to serve as a foundation of participants from which to draw for studies of preeclampsia, anticipated to evolve as our scientific understanding of preeclampsia evolves.

Conditions

  • Preeclampsia
  • Eclampsia
  • HELLP Syndrome
  • Toxemia
  • Hypertensive Disorder of Pregnancy

Sponsors & Collaborators

  • Preeclampsia Foundation

    lead OTHER

Principal Investigators

  • Eleni Z Tsigas, BA · Preeclampsia Foundation

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-01
Primary Completion
2040-05-31
Completion
2040-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06377878 on ClinicalTrials.gov